Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Journal of Applied Clinical Medical Physics
|
August 22, 2008
Dosimetric verification of micro-MLC based intensity modulated radiation therapy
Parminder Basran, Collins Yeboah
Journal of Applied Clinical Medical Physics
|
July 3, 2018
COMP Report: CPQR Technical Quality Control Guidelines for Data Management Systems
Natalie Pomerleau-Dalcourt, Parminder Basran
International Journal of Radiation Oncology, Biology, Physics
|
March 22, 2008
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results
Tee S Lim, Patrick C F Cheung, D Andrew Loblaw, et al.
BMC Cancer
|
October 6, 2018
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
Robert Olson, Mitchell Liu, Alanah Bergman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial
Matthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Journal of Applied Clinical Medical Physics
|
August 22, 2008
Dosimetric verification of micro-MLC based intensity modulated radiation therapy
Parminder Basran, Collins Yeboah
Journal of Applied Clinical Medical Physics
|
July 3, 2018
COMP Report: CPQR Technical Quality Control Guidelines for Data Management Systems
Natalie Pomerleau-Dalcourt, Parminder Basran
International Journal of Radiation Oncology, Biology, Physics
|
March 22, 2008
Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results
Tee S Lim, Patrick C F Cheung, D Andrew Loblaw, et al.
BMC Cancer
|
October 6, 2018
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
Robert Olson, Mitchell Liu, Alanah Bergman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 15, 2022
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial
Matthew Van Oirschot, Alanah Bergman, Wilko F A R Verbakel, et al.
Page
of 1